Case report: One case of refractory membranous nephropathy with hypokalemia after rituximab infusion was switched to obinutuzumab without recurrence of hypokalemia

• Główni autorzy: Yao Zhang (Autor), Jing Sun (Autor), Jie Gao (Autor), Weiyan Sun (Autor), Liang Xu (Autor), Chunjuan Zhai (Autor), WenYan Su (Autor), Haiping Wang (Autor)
• Format: Książka
• Wydane: Frontiers Media S.A., 2024-01-01T00:00:00Z.
• Hasła przedmiotowe: article
• Dostęp online: Connect to this object online.

Rituximab (RTX) is a monoclonal antibody commonly used to treat PLA2R-associated membranous nephropathy (MN). This report presents a case of refractory MN in a patient who experienced severe hypokalemia, a rare but clinically significant condition, after the 5th RTX infusion. Clinicians should be aw...